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Abstract: Metabolic Syndrome (MetS) contributes to the development of cardiovascular disease
(CVD) and type II diabetes mellitus (T2DM). Few studies have investigated the MetS risk of young
adults (18–24 years old). This study aims to determine the prevalence of MetS in Appalachian
and non-Appalachian students attending West Virginia University. The prevalence of MetS in this
population was 15%. There was no difference in MetS prevalence between male students and
female students (18.8% males and 11.1% females, p-value = 0.30), or between Appalachian students
and non-Appalachian students (17.7% Appalachian and 10.0% non-Appalachian, p-value = 0.33).
Identification of MetS early in life is needed in order to reduce the onset of chronic disease. Therefore,
implementing a screening process to identify at-risk young adults will help tailor more effective
behavioral interventions.
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1. Introduction
Metabolic Syndrome (MetS) contributes to the development of coronary heart disease (CHD) [1–3],
cardiovascular disease (CVD) [3], and type II diabetes mellitus (T2DM) [1–3]. MetS consists of five,
interrelated risk factors [4,5]. Individuals presenting three or more of the following risk factors are
diagnosed with MetS: Fasting blood glucose (FBG) ≥100 mg/dL, waist circumference (WC) >102 cm
for men and >88 cm for women, triglycerides (TG) ≥150 mg/dL, high density lipoprotein cholesterol
(HDL) <40 mg/dL for men and <50 mg/dL for women, and blood pressure (BP) ≥130/85 mmHg [6].
Few studies have investigated the MetS risk of young adults [1,7]. However, CHD is the second
leading cause of death in this age group [1], suggesting the need to detect for early warning signs of
this disease. Thus, screening for MetS in this population can be beneficial in identifying those at higher
risk from CHD development.
The prevalence of obesity has reached epidemic proportions within the Appalachian region [8,9],
which extends from Northeastern Mississippi to Southern New York [10], with its epicenter lying
entirely within the state of West Virginia (WV) [11]. The Appalachian region is characterized by
unhealthy eating behaviors and inactivity, which leads to the increased incidence of chronic disease
among this population [10]. Ely et al. recently reported the increased risk of chronic disease, related
to excessive weight gain and poor health behaviors, is not realistically perceived by Appalachian
residents [12]. Inadequate transportation [8], poverty [13,14], lack of access to medical care [8,13] and
lack of insurance are additional factors directly impacting the health disparities of individuals in this
region [13]. In 2009, Appalachians were 40% more likely to have diabetes than non-Appalachians [8].
In 2011, the prevalence of diagnosed diabetes was 9.8% within the Appalachian region and 7.8% in the
rest of the nation [15].
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In Ohio and WV, 25.6% of normal-weight adults display two or more of the following
cardio-metabolic abnormalities: High blood pressure, elevated TG, decreased HDL, elevated FBG,
and insulin resistance (IR) [9]. An estimated 50% of adults and adolescents residing in WV are obese by
Body Mass Index (BMI) classification: Normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2),
and obese (≥30 kg/m2) [8]. WV has reported the highest age-adjusted incidence of diabetes as well as
the highest diabetes-related deaths in the nation [8].
As many as 30% to 35% of college students are reported to be overweight or obese [7,16,17]
and obesity rates have increased most rapidly among individuals 18–29 years old with some college
education [7,16–18]. First year college students gain weight up to 11 times faster than adults [1].
This increase in weight increases the likelihood of developing MetS risk criteria [1,7]. Increased
weight and obesity, particularly abdominal obesity, is directly related to the development of MetS and
cardiovascular risk [5,19]. Screening for abnormal lipid values is recommended starting at 20 years
old [1]. Therefore, colleges and universities serve as important settings for the surveillance, prevention,
and intervention of hyperlipidemia, MetS, and CHD [20]. Targeting young adults that choose to attend
post-secondary institutions could aid in the prevention of CVD, CHD, and T2DM since many young
people develop a clearer sense of self and establish life-long behavior patterns during college [21].
The few studies of MetS prevalence in college students found that 27% [17], 28% [1], and 30% [16]
of students in the Northeast [1] and Midwest [16,17] regions exhibit at least one component of MetS.
In the same studies, 5.7% [16], 7.4% [1], and 14.3% [17] of college students had two components of MetS.
In the Southern US, 43% of students presented with at least one component of MetS [7]. When the
sample was limited to students who were overweight or obese, the rate of at least one component
of MetS rose to 82% [7]. Fernandes et al. found that 3.7% of college students presented with three
or more MetS risk components [1]. The latest study, conducted by Morrell et al., reported 77.2% of
males and 53.8% of females exhibited at least one component of MetS [22]. MetS was present in 9.9%
of males and 3.0% females [22]. Not only do overweight [1,17,22] and obese [1,22] students present
with MetS [1] and more MetS risk factors [17,22] than normal weight students, but obese students
exhibit significantly more MetS criteria than overweight students [22]. Overall, male students were
more likely to exhibit MetS risk criteria than female students [16] and the most prevalent MetS risk
component was low HDL [16,17,22], then FBG, and TG in decreasing order [16,17].
Due to the overall poorer health and higher risk factors in the Appalachian region discussed
previously, young adults in these regions are an important, yet overlooked, demographic to study their
MetS risk. This study aims to determine the prevalence of MetS in Appalachian and non-Appalachian
students attending West Virginia University.
2. Method
The measures for this cross-sectional study were collected in January and February 2011. Subjects
were recruited from West Virginia University. The Institutional Review Board (IRB) at West Virginia
University approved the study protocol in advance of commencement.
2.1. Subjects
Subjects (n = 93) were recruited via posted advertisements, in-class announcements,
and recruitment E-mails sent by instructors and campus administrators. Students were eligible if they
were 18–24 years old; had a BMI >18.5 kg/m2; were a first, second, or third year undergraduate; had
regular access to the Internet; were free from life-threatening illnesses or other health conditions; were
not pregnant; had no diet- and/or activity-related medical restrictions that prevented accurate physical
assessments; they were not currently enrolled in a nutrition course; and they were not majoring in
nutrition, exercise science, or health-promotion.
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2.2. Measures
Demographics (e.g., ethnicity), health-related practices (e.g., cigarette and medication use),
and Appalachian identity (from self-reported home address) were collected via questionnaire.
All clinical, anthropometric, and biochemical measurements were performed by trained staff.
Measurements were collected in the fasted state (>8 h) after participants had changed into light
clothing and voided. All female participants were screened for pregnancy.
Systolic and diastolic pressures were measured in triplicate (with 2 min rest intervals) in the
left arm midpoint between the shoulder and elbow via an automated cuff (HEM-907XL, Omron;
Lake Forest, IL, USA) after subjects were rested in a seated position for five minutes. Height was
measured by a wall-mounted, digital stadiometer (Heightronic 235, Quick Medical; Issaquah, WA,
USA) with subjects looking straight ahead and maintaining four points of contact (heels, buttocks,
shoulder blades, and back of the head) with the wall. Weight was measured by a digital scale (300A,
Tanita; Arlington Heights, IL, USA) which also calculated body mass index (BMI) from height input.
Waist circumference (WC) was measured in duplicate at the top of the iliac crest to the nearest 0.1 cm
using a non-stretchable tape measure with tensometer (Gulick, Creative Health Products; Plymouth,
MI, USA). Neck circumference (NC) was measured in duplicate at the point below the larynx to the
nearest 0.1 cm with the tape measure used for waist circumference.
Biochemical measures were obtained via finger-stick using a desktop LDX Cholestech Analyzer
(LDX, Cholestech; San Diego, CA, USA) following manufacturer’s instructions. Analyses for
high-density lipoprotein cholesterol (HDL), triglycerides (TG), fasting blood glucose (FBG), C-Reactive
Protein (CRP), and low-density lipoprotein cholesterol (LDL) were conducted via direct enzymatic
methods by the analyzer. The Cholestech LDX analyzer has been validated for precision and accuracy
against traditional laboratory techniques and offers logistical convenience for large-scale health
assessments [23]. Hemoglobin A1C (HbA1C) was measured using DCA Vantage. Hemoglobin
(Hgb) and hematocrit (Hct) weer measured using HemoPoint A2 (Boerne, TX, USA).
2.3. Statistical Analysis
BMI was categorized as normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2),
and obese (≥30.0 kg/m2). MetS and its five individual components were defined by the National
Cholesterol Education Program Adult Treatment Panel III: Fasting blood glucose (FBG) ≥100 mg/dL,
waist circumference (WC) >102 cm for men and >88 cm for women, triglycerides (TG) ≥150 mg/dL,
high density lipoprotein cholesterol (HDL) <40 mg/dL for men and <50 mg/dL for women, and blood
pressure (BP) ≥130/85 mmHg [6]. The presence of ≥3/5 components was categorized as MetS.
Student t-tests were performed to identify differences in anthropometric and biochemical
measures between males and females and Appalachians and non-Appalachians. Chi-square tests
were used to identify associations between prevalence rates of individual components and MetS,
and the following subject characteristics: Male, female, Appalachian, and non-Appalachian.
The Mantel-Haenszel test was used to assess the ordinal trend between males and females as well as
Appalachians and non-Appalachians. Statistical significance was defined as a p-value < 0.05. Statistical
analyses were performed using SAS 9.3 statistical software (SAS Institute Inc., Cary, NC, USA).
3. Results
Subjects were 51.6% male and 48.4% female; primarily White (82.8%) followed by Black (10.7%),
Latino (3.2%) and Asian (2.2%). Roughly, two thirds of the subjects identified themselves as
Appalachian (67.7%) and one third as non-Appalachian (32.3%). The majority (41.9%) of subjects were
first year, 30.1% were second year, and 25.8% third year undergraduate students. Table 1 provides
more descriptive characteristics.
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Table 1. Sample descriptive characteristics.
Total (n = 93) Percentage (%)
Sex
Female 45 48.4
Male 48 51.6
Ethnicity
Caucasian 77 82.8
African American 10 10.7
Hispanic/Latino 3 3.2
Asian 2 2.2
Not reported 1 1.1
Permanent address
Appalachian 63 67.7
Non-Appalachian 30 32.3
School year
First 39 41.9
Second 28 30.1
Third 24 25.8
Not reported 2 2.2
Table 2 shows that average subjects had normal BMIs with no significant differences between
male and female) subjects (p-value = 0.29). Waist circumference did not differ between male and female
subjects (p-value = 0.58) (Table 2). Males weighed significantly more than females (p-value < 0.01)
(Table 2). Female students presented with significantly higher HDL levels compared to males (p < 0.01)
(Table 3). Male students had higher systolic BP (p-value < 0.001), but not diastolic BP than females
(p-value = 0.60) (Table 3). No sex differences were observed for TG and FBG (Table 3).
Table 2. Baseline anthropometric measures by sex.
All (n = 93) Female (n = 45) Male (n = 48) Sex Differences
Measures Mean SD Mean SD Mean SD p-Value
Height (cm) 171.87 8.94 165.01 5.20 178.30 6.63 <0.0001 *
Weight (kg) 73.04 15.58 68.74 16.53 77.08 13.61 0.0092 *
BMI (kg/m2) 24.70 4.81 25.25 5.82 24.19 3.61 0.2930
BF (%) 22.84 10.64 30.22 8.89 15.91 6.79 <0.0001 *
WC (cm) 84.13 15.73 85.07 19.77 83.25 10.80 0.5796
NC (cm) 35.68 3.70 33.04 3.12 38.17 2.17 <0.0001 *
SD: Standard Deviation; BMI: Body Mass Index; BF: Body Fat; WC: Waist Circumference; NC: Neck Circumference;
* indicates significance.
Table 3. Baseline biochemical measures by sex.
All (n = 93) Female (n = 45) Male (n = 48) Sex Differences
Characteristic Mean SD Mean SD Mean SD p-Value
SBP (mmHg) 117.74 13.23 111.27 9.68 123.80 13.30 <0.0001 *
DBP (mmHg) 69.41 8.97 69.91 9.21 68.94 8.82 0.6038
LDL-C (mg/dL) 97.73 29.23 100.18 27.00 95.14 31.60 0.4618
HDL-C (mg/dL) 53.06 18.79 58.84 18.31 47.65 17.76 0.0035 *
TC (mg/dL) 165.72 36.54 176.82 38.06 155.30 32.08 0.004 *
TG (mg/dL) 99.51 57.69 107.38 61.86 92.13 53.06 0.2043
FBG (mg/dL) 98.84 13.87 97.38 15.97 100.21 11.57 0.3280
HBA1c (%) 5.28 0.40 5.31 0.50 5.25 0.29 0.4869
SD: Standard Deviation; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; LDL-C: Low Density
Lipoprotein Cholesterol; HDL-C: High Density Lipoprotein Cholesterol; TC: Total Cholesterol; TG: Triglycerides;
FBG: Fasting Blood Glucose; HBA1c: Hemoglobin A1C; * Indicates Significance.
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Appalachian and non-Appalachian student comparisons revealed no significant differences in
anthropometric measures (height, weight, BMI, and WC) or biochemical measures (HDL, TG and
FBG) (Table 4). Appalachian students presented with elevated FBG (37.1%), low HDL (35.5%), at-risk
WC (21.0%), elevated TG (21.0%), and elevated BP (19.4%). Non-Appalachian students presented
with elevated FBG (36.7%) low HDL (36.7%), elevated BP (23.3%), at-risk WC (16.7%) and elevated
TG (13.3%) (Table 5). The prevalence of individual MetS components was not significantly different
between Appalachian and non-Appalachian students.
Table 4. Biochemical and anthropometric measures by region.
All
(n = 93)
Appalachian
(n = 62)
Non-Appalachian
(n = 30)
Regional
Differences
Characteristic Mean SD Mean SD Mean SD p-value
Height (cm) 171.87 8.94 170.94 9.00 174.22 8.33 0.097
Weight (kg) 73.04 15.58 73.19 16.78 73.05 13.3 0.968
BMI (kg/m2) 24.70 4.81 25.04 5.40 23.99 3.34 0.332
BF (%) 22.84 10.64 23.37 11.27 21.45 9.30 0.420
WC (cm) 84.13 15.37 83.28 13.56 82.67 9.38 0.825
NC (cm) 35.68 3.70 35.51 3.79 36.12 3.58 0.466
SBP (mmHg) 117.74 13.23 117.63 12.92 118.07 14.27 0.833
DBP (mmHg) 69.41 8.97 70.18 8.60 67.93 9.80 0.265
LDL-C (mg/dL 97.93 29.23 101.21 32.39 87.81 16.50 0.076
HDL-C (mg/dL) 53.06 18.79 53.34 19.55 52.50 17.75 0.843
TC (mg/dL) 165.72 36.64 171.39 38.58 152.77 28.43 0.021 *
TG (mg/dL) 99.51 57.69 104.95 60.17 87.00 51.64 0.164
FBG (mg/dL) 98.84 13.87 99.02 15.43 98.30 10.40 0.819
HBA1c (%) 5.28 0.40 5.32 0.44 5.18 0.29 0.115
SD: Standard Deviation; BMI: Body Mass Index; BF: Body Fat; WC: Waist Circumference; NC: Neck Circumference;
SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; LDL-C: Low Density Lipoprotein Cholesterol; HDL-C:
High Density Lipoprotein Cholesterol; TC: Total Cholesterol; TG: Triglycerides; FBG: Fasting Blood Glucose; HBA1c:
Hemoglobin A1C; * indicates significance.
Table 5. Rates of individual metabolic syndrome components.
MetS Component
Number (%) with MetS Component (Total n/Percentage %)
Overall Males Females p-Value App Non-App p-Value 1
Elevated WC 18 (19.4%) 4 (8.3%) 14 (31.1%) 0.0055 * 13 (21.0%) 5 (16.7%) 0.6259
Elevated BP 19 (20.4%) 15 (31.3%) 4 (8.9%) 0.0075 * 12 (19.4%) 7 (23.3%) 0.6586
Elevated TGs 17 (18.3%) 8 (16.7%) 9 (20.0%) 0.6777 13 (21.0%) 4 (13.3%) 0.3765
Elevated FBG 35 (37.6%) 23 (47.9%) 12 (26.7%) 0.0345 * 23 (37.1%) 11 (36.7%) 0.968
Low HDL-C 33 (35.5%) 19 (39.6%) 14 (31.1%) 0.3935 22 (35.5%) 11 (36.7%) 0.9117
App: Appalachian; WC: Waist Circumference; BP: Blood Pressure; TGs: Triglycerides; FBG: Fasting Blood Glucose;
HDL-C: High Density Lipoprotein Cholesterol; 1 Chi-Square test; * indicates significance.
The most prevalent MetS component in the total sample was elevated FBG (37.6%), followed
by low HDL (35.5%), elevated BP (20.4%), at-risk WC (19.4%) and elevated TG (18.3%) (Table 5).
Male students presented with elevated FBG (47.9%), followed by low HDL (39.6%), elevated BP (31.3%),
elevated TG (16.7%), and at-risk WC (8.3%), whereas, female students presented with low HDL (31.1%)
and at-risk WC (31.1%), followed by elevated FBG (26.7%), elevated TG (20.0%), and elevated BP
(8.9%) (Table 5). Overall, significantly more female students exhibited at-risk WC than males (p < 0.01),
whereas, significantly more male students displayed elevated BP (p < 0.01) and FBG (p < 0.05) (Table 5).
Twenty-eight percent of students presented with zero components of MetS; 33.1% with one
component; and 23.7% with two components (Table 6). The prevalence of MetS in this population
was 15%. Specifically, 10.8% presented with three components, 3.2% with four components, and 1.1%
with all five components of MetS (Table 6). There was no significant difference between male and female
students in MetS prevalence (p-value = 0.30) or between Appalachian students and non-Appalachian
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students (p-value = 0.33) (Table 6). There were no significant associations between the number of MetS
components by sex (p = 0.28) or by Appalachian identity (p = 0.78) (Table 6).
Table 6. Frequency of metabolic syndrome and number of metabolic syndrome components.
Demographic
Variable
n Total n (%)
with MetS
p-Value 1
Number of MetS Components (Total n/Percentage %)
p-Value 2
0 1 2 3 4 5
Overall 93 14(15.1%) -
26
(28.0%)
31
(33.3%)
22
(23.7%)
10
(10.8%)
3
(3.2%)
1
(1.1%)
Sex
0.3033 0.2770
Males 48 9(18.8%)
12
(25.0%)
15
(33.3%)
12
(25.0%)
6
(12.5%)
3
(6.3%)
0
(0.0%)
Females 45 5(11.1%)
14
(31.1%)
16
(35.6%)
10
(22.2%)
4
(8.9%)
0
(0.0%)
1
(2.2%)
Region
0.3325 0.7795
Appalachian 62 11(17.7%)
18
(29.0%)
19
(30.7%)
14
(22.6%)
9
(14.5%)
1
(1.6%)
1
(1.6%)
Non-Appalachian 30 3(10.0%)
8
(26.7%)
11
(36.7%)
8
(26.7%)
1
(3.3%)
2
(6.7%)
0
(0.0%)
MetS: Metabolic Syndrome; 1 Chi Square Test; 2 Mantel-Haenszel test for trend.
4. Discussion
The prevalence of MetS students at West Virginia University (15.1%) is much higher than what has
been reported in previous studies (0.6% to 10%) of MetS prevalence in college students [1,7,16,17,22].
Previous studies have reported the prevalence of MetS in young adults to be 0.6% [17] and 1.3% [16]
in the Midwest region, 3.7% [1] in the Northeast region and up to 10% in the Southeast region.
Additionally, in the Northeast 7% [1]; and in the Midwest 14% [17] and 6% [16] of students had two
MetS risk factors, while 24% had two MetS risk factors in the Appalachian region. Showing that
Appalachia has a markedly higher incidence of MetS [1,7,16,17,22] and MetS risk factors [1,16,17] than
other regions of the US.
In a direct comparison of West Virginia University students to students from two Northeast
universities (NEU1 and NEU2), the prevalence of MetS was significantly greater at WVU than both
NEU1 (p-value < 0.05) and NEU2 (p-value < 0.05) [24]. The surprising lack of a significant difference
between Appalachian and non-Appalachian student identity and the higher prevalence of MetS in
WVU students suggests that an unidentified factor may be mediating the relationship with higher
incidence of MetS in this population. One possible factor is BMI. Upon examining correlations between
BMI and MetS components significant relationships were found. Specifically, BMI was significantly
correlated with students presenting with at-risk WC (R2 = 0.86, p < 0.05), low HDL (R2 = −0.43,
p < 0.05), elevated BP (R2 = 0.29, p < 0.05) and increased TG (R2 = 0.22, p < 0.05). No correlation was
found between BMI and impaired FBG measures.
There are several limitations to this study. First, this was a small sample size of students. While this
area of study is important, having a larger sample size would have increased the impact of these
results. Overall, there was a generally low prevalence of MetS in this sample. Future work would
include a larger sample size to have more impactful results.
These data identify the need for university administrators throughout the nation to implement
health initiatives to measure BMI and screen for MetS components in students to prevent the
development of chronic disease. Data from such screenings for college students will provide
researchers, public health officials, and administrators with information to use to design, tailor,
and implement effective interventions to prevent chronic disease progression across various
university settings.
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